Maternal Proton Pump Inhibitor Use During Pregnancy and Risk of Low Birth Weight in Offspring in Korea, 2008-2019

JAMA Netw Open. 2023 Apr 3;6(4):e237962. doi: 10.1001/jamanetworkopen.2023.7962.

Ahhyung Choi¹, Yunha Noh^{1

2

3}, Dong Keon Yon⁴, Ju-Young Shin^{1

2

5}

¹ School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
² Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea.
³ Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
⁴ Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea.
⁵ Department of Clinical Research Design & Evaluation, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, South Korea.

No abstract available

Plain language summary

This cohort study examines whether the risk of low birth weight is associated with prenatal exposure to proton pump inhibitors.